Categories: Health

Transactions under Novonesis share buyback program

Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated  1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025.

Please read the full announcement in PDF.

Attachment

GlobeNews Wire

Recent Posts

EUROAPI_Liquidity Contract

 Press Release Paris 30 avril, 2026 Share buyback program Reduction in the Resources Allocated under…

4 hours ago

Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA

LONDON, April 30, 2026 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, announced it…

4 hours ago

Nicox Provides Full Year 2025 Financial Results and Corporate Update

April 30, 2026 01:30 ET  | Source: NICOX SA Press Release Nicox Provides Full Year…

4 hours ago

India’s Most Distinguished Cybersecurity and Defence Strategist Joins Synergy Quantum to Fortify the Nation’s Quantum Sovereignty

Lt Gen Madhavan Unnikrishnan Nair (Retd.), AVSM, SM ,Former National Cyber Security Coordinator, Government of…

4 hours ago

Shaping Future-Ready School Leaders: Woxsen University Leads Design Thinking Initiative for Principals

HYDERABAD, India, April 30, 2026 /PRNewswire/ -- The School of Arts and Design at Woxsen University,…

4 hours ago

Driving the Global Food Revolution: Japan’s Cutting-Edge Food Processing Technology Takes Center Stage

FOOMA JAPAN 2026 to Showcase Next-Generation Solutions Shaping the Future of Food Processing and Global…

4 hours ago